Angel Investments
Lamark Biotech raises Rs.6.5 Cr led by IAN Group
Bengaluru-based biopharma startup Lamark Biotech has raised INR 6.5 crore in a pre-Series A round led by IAN Group including IAN Alpha Fund, Vinayender Tulla, Nita Roy, and Venkataraman KNK. The company had previously raised USD 413,000 in a seed funding round led by VIT-TBI and others.The proceeds will be used to accelerate the development of thermostable insulin and expand the biologics platform for global access.Founded in 2018 by Vaibhav Bhatia, Lamark Biotech develops innovative molecular medicines to support sustainable and affordable healthcare systems by enabling the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
